MRK news

• If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys

  Fool - Investing News · Oct 17, 2026
• Merck & Co., Inc. $MRK Stock: Banque Pictet & Cie SA Cuts Holdings

  Defense World · Oct 17, 2026
• Merck Stock: Watch This Price, Prepare To Profit From This Trade

  Investors Business Daily · Oct 16, 2026
• The Stocks That Will Get Investors Home Safe When Tech Cracks

  24/7 Wall Street · Oct 16, 2026
• The Big 3: MRK, GILD, XOM

  Schwab Network · Oct 15, 2026
• AMGN vs. MRK: Which Pharma Giant's Dividend Actually Has Room to Grow

  24/7 Wall Street · Oct 15, 2026
• Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

  Zacks Investment Research · Oct 15, 2026
• Merck & Co., Inc. $MRK Stock: Cliftonlarsonallen Wealth Advisors LLC Cuts Holdings

  Defense World · Oct 15, 2026
• Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make

  CNBC · Oct 14, 2026
• Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?

  Zacks Investment Research · Oct 14, 2026
• How to Turn $500,000 Into a Lazy $16,500 Yearly Passive Income Stream

  247 Wallst · Oct 14, 2026
• Merck & Co., Inc. $MRK Position Cut by Perpetual Ltd

  Defense World · Oct 14, 2026
• Merck (MRK) Dips More Than Broader Market: What You Should Know

  Zacks Investment Research · Oct 13, 2026
• FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban

  Business Insider · Oct 13, 2026
• Merck & Co., Inc. $MRK Position Increased by NorthCrest Asset Manangement LLC

  Defense World · Oct 13, 2026
• Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors

  Business Wire · Oct 13, 2026
• Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026

  Business Wire · Oct 13, 2026
• Jefferies cuts Merck's remigromig sales forecast after eye-disease trial raises concerns

  Proactive Investors · Oct 12, 2026
• Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines

  Zacks Investment Research · Oct 12, 2026
• Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?

  Zacks Investment Research · Oct 12, 2026
• These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?

  Fool - Investing News · Oct 12, 2026
• Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic

  GuruFocus · Oct 10, 2026
• Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026

  Business Wire · Oct 10, 2026
• Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

  Fool - Investing News · Oct 10, 2026
• Breakfast News: The Quarter in Charts

  Fool - Investing News · Oct 10, 2026
• This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street

  Fool - Investing News · Oct 9, 2026
• Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

  24/7 Wall Street · Oct 9, 2026
• Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

  24/7 Wall Street · Oct 9, 2026
• Merck & Co., Inc. $MRK Stake Raised by GAMMA Investing LLC

  Defense World · Oct 9, 2026
• Apella Capital LLC Increases Stake in Merck & Co., Inc. $MRK

  Defense World · Oct 9, 2026

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.